| Ask Questions About Clinical Trials (NCT07343297) | Barbara Ann Karmanos Cancer Institute | 2026-12-30 |
| A Study of the TheraBionic P1 Device in Breast Cancer (NCT07218432) | Barbara Ann Karmanos Cancer Institute | 2026-10-01 |
| Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing (NCT07743086) | Barbara Ann Karmanos Cancer Institute | 2026-09-01 |
| Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression (NCT07672431) | Barbara Ann Karmanos Cancer Institute | 2026-09-01 |
| Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors (NCT07436078) | Barbara Ann Karmanos Cancer Institute | 2026-04-18 |
| A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer (NCT07227831) | Barbara Ann Karmanos Cancer Institute | 2026-02-01 |
| TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma (NCT07118202) | Barbara Ann Karmanos Cancer Institute | 2025-10-20 |
| Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies (NCT07098299) | Barbara Ann Karmanos Cancer Institute | 2025-09-18 |
| Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer (NCT07130903) | Barbara Ann Karmanos Cancer Institute | 2025-09-10 |
| A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. (NCT07095114) | Barbara Ann Karmanos Cancer Institute | 2025-08-18 |
| Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer (NCT06576115) | Barbara Ann Karmanos Cancer Institute | 2025-02-28 |
| Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors (NCT06908629) | Barbara Ann Karmanos Cancer Institute | 2024-09-03 |
| Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma (NCT06107738) | Barbara Ann Karmanos Cancer Institute | 2023-12-21 |
| Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer (NCT03875053) | Barbara Ann Karmanos Cancer Institute | 2023-07-25 |
| Dietary Reporting In The Amyloidoses (NCT05738005) | Barbara Ann Karmanos Cancer Institute | 2023-03-02 |
| A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions (NCT07042191) | Barbara Ann Karmanos Cancer Institute | 2022-12-09 |
| F-Tryptophan PET/CT in Human Cancers (NCT05556473) | Barbara Ann Karmanos Cancer Institute | 2022-09-29 |
| Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant (NCT05222438) | Barbara Ann Karmanos Cancer Institute | 2022-04-08 |
| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies (NCT05028374) | Barbara Ann Karmanos Cancer Institute | 2021-08-17 |
| Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma (NCT04397679) | Barbara Ann Karmanos Cancer Institute | 2021-08-12 |
| Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma (NCT04479267) | Barbara Ann Karmanos Cancer Institute | 2020-08-21 |
| DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer (NCT04282343) | Barbara Ann Karmanos Cancer Institute | 2020-02-25 |
| Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care (NCT04266522) | Barbara Ann Karmanos Cancer Institute | 2020-01-16 |
| C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience) (NCT03750981) | Barbara Ann Karmanos Cancer Institute | 2018-11-12 |
| Reducing Metabolic Syndrome Among Breast Cancer Survivors (NCT03719677) | Barbara Ann Karmanos Cancer Institute | 2018-11-06 |
| Tobacco Cessation Intervention (NCT03657511) | Barbara Ann Karmanos Cancer Institute | 2018-10-22 |
| Feasibility and Utilization of an Application-based Question Prompt List (NCT03676920) | Barbara Ann Karmanos Cancer Institute | 2018-08-21 |
| AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm (NCT03453489) | Barbara Ann Karmanos Cancer Institute | 2018-06-20 |
| Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03406858) | Barbara Ann Karmanos Cancer Institute | 2018-06-07 |
| Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo (NCT03421652) | Barbara Ann Karmanos Cancer Institute | 2018-04-24 |
| ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer (NCT03456804) | Barbara Ann Karmanos Cancer Institute | 2018-03-08 |
| Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment (NCT03683420) | Barbara Ann Karmanos Cancer Institute | 2018-02-14 |